May 12, 2020
1 min read

City of Hope names pathology department chair, lymphoma center associate director

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Stanley R. Hamilton, MD 
Stanley R. Hamilton
Alexey Danilov, MD, PhD 
Alexey Danilov

City of Hope announced two new key hires.

Stanley R. Hamilton, MD, has been named chair of the department of pathology.

Hamilton — a gastrointestinal and molecular pathologist — brings more than 4 decades of expertise to his role. He previously served as head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.

Hamilton’s goals include making sure every patient has access to state-of-the-art specialized pathology, improving and enhancing biomarker data used in clinical trials and integrating digital pathology into the overall informatics of the institution.

“Pathology is central to achieving success in many of our strategic priorities, including precision medicine, cellular therapy, biomarker discovery and clinical research,” Michael Caligiuri, MD, president of City of Hope National Medical Center, said in a press release. “Dr. Hamilton's strength as a clinician, researcher and collaborator will be critical as we continue our pursuit to sequence every cancer patient here at a City of Hope in order to best understand and treat their disease.”

Alexey Danilov, MD, PhD, has been named associate director of City of Hope’s Toni Stephenson Lymphoma Center.

Danilov has received numerous honors and awards for his role in the study and treatment of chronic lymphocytic leukemia and many forms of lymphoma.

Danilov focuses primarily on identifying cell proteins — those that promote cancer and others that inhibit it — learning how they deteriorate and finding drugs that can affect the process.

Danilov previously served as associate professor of medicine at Oregon Health & Science University.

“He’s a clinician as well as a scientist, and he brings patient issues into the lab,” lab staffer Tingting Liu, PhD, said in the release. “He’s always reminding us that our primary drive must be what’s best for the patient.”